{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:20:19Z","timestamp":1793380819127,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001554","name":"Massey University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.neuro.2022.09.008","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T03:01:11Z","timestamp":1663902071000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke"],"prefix":"10.1016","volume":"93","author":[{"given":"Sa Weon","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Teesdale-Spittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Truman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2022.09.008_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cbi.2016.06.005","article-title":"Combining in vitro and in silico approaches to evaluate the multifunctional profile of rosmarinic acid from Blechnum brasiliense on targets related to neurodegeneration","volume":"254","author":"Andrade","year":"2016","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ardp.201500317","article-title":"Monoamine oxidase inhibitory activity of ferulic acid amides: curcumin\u2010based design and synthesis","volume":"349","author":"Badavath","year":"2016","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.neuro.2022.09.008_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuint.2016.01.001","article-title":"Effect of scopoletin on monoamine oxidases and brain amines","volume":"93","author":"Basu","year":"2016","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nsb732","article-title":"Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders","volume":"9","author":"Binda","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"13\u201314","key":"10.1016\/j.neuro.2022.09.008_bib5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.addr.2008.06.002","article-title":"Monoamine oxidase inactivation: from pathophysiology to therapeutics","volume":"60","author":"Bortolato","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/adb.12099","article-title":"Tobacco particulate matter self\u2010administration in rats: differential effects of tobacco type","volume":"20","author":"Brennan","year":"2015","journal-title":"Addict. Biol."},{"issue":"24","key":"10.1016\/j.neuro.2022.09.008_bib7","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.85.24.9788","article-title":"Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco","volume":"85","author":"Bryant","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuro.2022.09.008_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.5604\/17322693.1156936","article-title":"Hemoglobin adducts as biomarkers of human exposure to selected xenobiotics","volume":"69","author":"Bukowska","year":"2015","journal-title":"Post. Hig. i Med. doswiadczalnej"},{"issue":"2\u20133","key":"10.1016\/j.neuro.2022.09.008_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejphar.2010.06.043","article-title":"Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems","volume":"643","author":"Capra","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11030-013-9490-6","article-title":"Selective MAO-B inhibitors: a lesson from natural products","volume":"18","author":"Carradori","year":"2014","journal-title":"Mol. Divers."},{"issue":"47","key":"10.1016\/j.neuro.2022.09.008_bib11","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jafc.6b03529","article-title":"Inhibition of human monoamine oxidase: biological and molecular modeling studies on selected natural flavonoids","volume":"64","author":"Carradori","year":"2016","journal-title":"J. Agric. Food Chem."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2022.09.008_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0161-813X(03)00107-4","article-title":"Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links","volume":"25","author":"Castagnoli","year":"2004","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10298420290015854","article-title":"Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase","volume":"4","author":"Castagnoli","year":"2002","journal-title":"Neurotox. Res"},{"issue":"24","key":"10.1016\/j.neuro.2022.09.008_bib14","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1016\/j.bmc.2011.10.049","article-title":"Molecular insights into human monoamine oxidase (MAO) inhibition by 1, 4-naphthoquinone: evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAO","volume":"19","author":"Cerqueira","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41593-019-0563-4","article-title":"Dopamine fuels its own release","volume":"23","author":"Chen","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neuro.2022.09.008_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/np060015w","article-title":"Quercetin as the active principle of hypericum h ircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study","volume":"69","author":"Chimenti","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.neuro.2022.09.008_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.sajb.2021.09.019","article-title":"Promising botanical-derived monoamine oxidase (MAO) inhibitors: pharmacological aspects and structure-activity studies","volume":"146","author":"Das","year":"2022","journal-title":"South Afr. J. Bot."},{"issue":"36","key":"10.1016\/j.neuro.2022.09.008_bib18","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1073\/pnas.0505975102","article-title":"Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B","volume":"102","author":"De Colibus","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.neuro.2022.09.008_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2174\/1570159X15666171128143650","article-title":"3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors","volume":"16","author":"Dhiman","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.neuro.2022.09.008_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00702-010-0537-x","article-title":"Dietary inhibitors of monoamine oxidase A","volume":"118","author":"Dixon Clarke","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.neuro.2022.09.008_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neubiorev.2009.07.013","article-title":"Smoking, nicotine and neuropsychiatric disorders","volume":"34","author":"Dome","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jat\/2.1.21","article-title":"Aza-arenes in tobacco smoke","volume":"2","author":"Dong","year":"1978","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2022.09.008_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/164_2020_384","article-title":"Monoamine oxidase inhibitors: from classic to new clinical approaches","author":"Duarte","year":"2020","journal-title":"React. Oxyg. Species"},{"issue":"20","key":"10.1016\/j.neuro.2022.09.008_bib24","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/bi900413g","article-title":"Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases","volume":"48","author":"Edmondson","year":"2009","journal-title":"Biochemistry"},{"issue":"02","key":"10.1016\/j.neuro.2022.09.008_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4236\/ojd.2017.62004","article-title":"Monoamine oxidase inhibitors\u2014revisiting a therapeutic principle","volume":"6","author":"Entzeroth","year":"2017","journal-title":"Open J. Depress"},{"key":"10.1016\/j.neuro.2022.09.008_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.neuro.2022.09.008_bib27","unstructured":"Food and Drug Administration. (2021). FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them. Available from \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-tobacco-products-help-reduce-exposure-and-consumption-nicotine-smokers-who\u3009 (accessed 4 May 2022)."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0161-813X(02)00109-2","article-title":"Monoamine oxidase and cigarette smoking","volume":"24","author":"Fowler","year":"2003","journal-title":"Neurotoxicology"},{"issue":"6567","key":"10.1016\/j.neuro.2022.09.008_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/379733a0","article-title":"Inhibition of monoamine oxidase B in the brains of smokers","volume":"379","author":"Fowler","year":"1996","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.neuro.2022.09.008_bib30","doi-asserted-by":"crossref","first-page":"14065","DOI":"10.1073\/pnas.93.24.14065","article-title":"Brain monoamine oxidase A inhibition in cigarette smokers","volume":"93","author":"Fowler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2\u20133","key":"10.1016\/j.neuro.2022.09.008_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tox.2011.11.014","article-title":"Cigarette smoke induces p-benzoquinone-albumin adduct in blood serum: implications on structure and ligand binding properties","volume":"292","author":"Ghosh","year":"2012","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.neuro.2022.09.008_bib32","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1021\/acs.jafc.5b06043","article-title":"Kaempferol as selective human MAO-A inhibitor: analytical detection in calabrian red wines, biological and molecular modeling studies","volume":"64","author":"Gidaro","year":"2016","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.neuro.2022.09.008_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1017\/S1092852919001196","article-title":"Revitalizing monoamine oxidase inhibitors: a call for action","volume":"25","author":"Gillman","year":"2020","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41593-019-0556-3","article-title":"Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain","volume":"23","author":"Graves","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"38","key":"10.1016\/j.neuro.2022.09.008_bib35","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1523\/JNEUROSCI.2139-05.2005","article-title":"Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats","volume":"25","author":"Guillem","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02977772","article-title":"Monoamine oxidase inhibitory components from Cayratia japonica","volume":"30","author":"Han","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neuro.2022.09.008_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pnpbp.2016.02.013","article-title":"The role of MAO in personality and drug use","volume":"69","author":"Harro","year":"2016","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuro.2022.09.008_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0024-3205(00)01022-5","article-title":"2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity","volume":"68","author":"Hauptmann","year":"2001","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2004.11.033","article-title":"Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors","volume":"326","author":"Herraiz","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.neuro.2022.09.008_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ntr\/ntv245","article-title":"Contribution of monoamine oxidase inhibition to tobacco dependence: a review of the evidence","volume":"18","author":"Hogg","year":"2016","journal-title":"Nicotine Tob. Res"},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/13880209.2020.1790618","article-title":"Marine natural products with monoamine oxidase (MAO) inhibitory activity","volume":"58","author":"Hong","year":"2020","journal-title":"Pharm. Biol."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2022.09.008_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0006-8993(02)04050-7","article-title":"Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-\u03b2 peptide","volume":"963","author":"Irie","year":"2003","journal-title":"Brain Res."},{"issue":"23","key":"10.1016\/j.neuro.2022.09.008_bib43","doi-asserted-by":"crossref","first-page":"11141","DOI":"10.1158\/0008-5472.CAN-07-1369","article-title":"Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo","volume":"67","author":"Kang","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.neuro.2022.09.008_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1248\/bpb.29.483","article-title":"Effect of Acori graminei Rhizoma on contractile dysfunction of ischemic and reperfused rat heart","volume":"29","author":"Kang","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"10","key":"10.1016\/j.neuro.2022.09.008_bib45","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.bmc.2005.12.057","article-title":"Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke","volume":"14","author":"Khalil","year":"2006","journal-title":"Bioorg. Med Chem."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/tx990146f","article-title":"Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves","volume":"13","author":"Khalil","year":"2000","journal-title":"Chem. Res Toxicol."},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4062\/biomolther.2012.20.2.214","article-title":"Monoamine oxidase and dopamine Beta-hydroxylase Inhibitors from the fruits of Gardenia jasminoides","volume":"20","author":"Kim","year":"2012","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.neuro.2022.09.008_bib48","article-title":"Phenolic acids: Natural versatile molecules with promising therapeutic applications","volume":"24","author":"Kumar","year":"2019","journal-title":"Biotechnol. Rep. (Amst.)"},{"issue":"3","key":"10.1016\/j.neuro.2022.09.008_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-3223(03)00543-2","article-title":"Depression in Alzheimer's disease: heterogeneity and related issues","volume":"54","author":"Lee","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuro.2022.09.008_bib50","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1021\/jf010622j","article-title":"Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don","volume":"49","author":"Lee","year":"2001","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.neuro.2022.09.008_bib51","first-page":"179","article-title":"Phenolics with inhibitory activity on mouse brain monoamine oxidase (MAO) from whole parts of Artemisia vulgaris L (Mugwort)","volume":"9","author":"Lee","year":"2000","journal-title":"Food Sci. Biotechnol."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuro.2006.05.019","article-title":"Monoamine oxidase and tobacco dependence","volume":"28","author":"Lewis","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2022.09.008_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2016.01.004","article-title":"Synthesis and structure-activity relationship studies of novel 3,9-substituted alpha-carboline derivatives with high cytotoxic activity against colorectal cancer cells","volume":"110","author":"Lin","year":"2016","journal-title":"Eur. J. Med Chem."},{"issue":"13","key":"10.1016\/j.neuro.2022.09.008_bib54","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1039\/C4AY00271G","article-title":"Quantitation of ten flavor compounds in unburned tobacco products","volume":"6","author":"Lisko","year":"2014","journal-title":"Anal. Methods"},{"issue":"4","key":"10.1016\/j.neuro.2022.09.008_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002018-199614040-00002","article-title":"Monoamine oxidase inhibitors","volume":"14","author":"Livingston","year":"1996","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.neuro.2022.09.008_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1039856216634824","article-title":"MAOIs\u2013does the evidence warrant their resurrection?","volume":"24","author":"Menkes","year":"2016","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.neuro.2022.09.008_bib57","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejmech.2017.04.055","article-title":"The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase","volume":"135","author":"Mostert","year":"2017","journal-title":"Eur. J. Med Chem."},{"issue":"11","key":"10.1016\/j.neuro.2022.09.008_bib58","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0024-3205(87)90570-4","article-title":"Quinoline and quninaldine as naturally-occurring inhibitors specific for type-a monoamine-oxidase","volume":"40","author":"Naoi","year":"1987","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3940(87)90589-1","article-title":"1,4-benzoquinone as a new inhibitor of monoamine-oxidase","volume":"77","author":"Naoi","year":"1987","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1013853909494","article-title":"Secondary metabolism in tobacco","volume":"68","author":"Nugroho","year":"2002","journal-title":"Plant Cell Tissue Organ Cult."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0021-5198(19)44548-4","article-title":"Effect of diethylnitrosamine on monoamine oxidase in rat liver","volume":"49","author":"Obata","year":"1989","journal-title":"Jpn. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuro.2022.09.008_bib62","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jep.2008.02.015","article-title":"Isolation of the MAO-inhibitor naringenin from Mentha aquatica L","volume":"117","author":"Olsen","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.neuro.2022.09.008_bib63","first-page":"215","article-title":"The complexity of tobacco and tobacco smoke","volume":"24","author":"Perfetti","year":"2011","journal-title":"Beitr. Tab. Int."},{"issue":"10","key":"10.1016\/j.neuro.2022.09.008_bib64","doi-asserted-by":"crossref","first-page":"eaay9763","DOI":"10.1126\/sciadv.aay9763","article-title":"Current advances in research in treatment and recovery: Nicotine addiction","volume":"5","author":"Prochaska","year":"2019","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.neuro.2022.09.008_bib65","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-018-1861-9","article-title":"Kinetics, mechanism, and inhibition of monoamine oxidase","volume":"125","author":"Ramsay","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"7","key":"10.1016\/j.neuro.2022.09.008_bib66","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00702-011-0657-y","article-title":"An improved approach to steady-state analysis of monoamine oxidases","volume":"118","author":"Ramsay","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neuro.2022.09.008_bib67","series-title":"The Chemical Components of Tobacco and Tobacco Smoke","author":"Rodgman","year":"2013"},{"issue":"3\u20134","key":"10.1016\/j.neuro.2022.09.008_bib68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","article-title":"Nicotine and nonnicotine factors in cigarette addiction","volume":"184","author":"Rose","year":"2006","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neuro.2022.09.008_bib69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14622200110087277","article-title":"Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms","volume":"3","author":"Rose","year":"2001","journal-title":"Nicotine Tob. Res"},{"issue":"6","key":"10.1016\/j.neuro.2022.09.008_bib70","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/1871527314666150325235608","article-title":"Monoamine oxidase inhibitors extracted from tobacco smoke as neuroprotective factors for potential treatment of Parkinson's disease","volume":"14","author":"Sari","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"13","key":"10.1016\/j.neuro.2022.09.008_bib71","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1021\/ac50021a013","article-title":"Redox potential and quinone content of cigarette smoke","volume":"49","author":"Schmeltz","year":"1977","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuro.2022.09.008_bib72","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jff.2015.06.018","article-title":"Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects - a review","volume":"18","author":"Shahidi","year":"2015","journal-title":"J. Funct. Foods"},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0165-2370(01)00126-7","article-title":"Effect of reaction conditions on pyrolysis of chlorogenic acid","volume":"62","author":"Sharma","year":"2002","journal-title":"J. Anal. Appl. Pyrolysis"},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2022.09.008_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/toxsci\/69.1.265","article-title":"The relative toxicity of substituted phenols reported in cigarette mainstream smoke","volume":"69","author":"Smith","year":"2002","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.neuro.2022.09.008_bib76","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/npp.2016.36","article-title":"Effects of monoamine oxidase inhibition on the reinforcing properties of low-dose nicotine","volume":"41","author":"Smith","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuro.2022.09.008_bib77","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/pcp\/pcz076","article-title":"The age of coumarins in plant-microbe interactions","volume":"60","author":"Stringlis","year":"2019","journal-title":"Plant Cell Physiol."},{"key":"10.1016\/j.neuro.2022.09.008_bib78","unstructured":"Sub Laban, T.,\u00a0Saadabadi, A. (2021). Monoamine Oxidase Inhibitors (MAOI). In StatPearls. StatPearls Publishing. \u3008https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30969670\u3009."},{"issue":"10","key":"10.1016\/j.neuro.2022.09.008_bib79","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.euroneuro.2007.02.013","article-title":"Role of acetaldehyde in tobacco smoke addiction","volume":"17","author":"Talhout","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"15","key":"10.1016\/j.neuro.2022.09.008_bib80","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1016\/j.bmc.2005.04.081","article-title":"Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity","volume":"13","author":"Tao","year":"2005","journal-title":"Bioorg. Med Chem."},{"issue":"11","key":"10.1016\/j.neuro.2022.09.008_bib81","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-018-1881-5","article-title":"90 years of monoamine oxidase: some progress and some confusion","volume":"125","author":"Tipton","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuro.2022.09.008_bib82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejmech.2018.01.003","article-title":"Privileged scaffolds as MAO inhibitors: retrospect and prospects","volume":"145","author":"Tripathi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuro.2022.09.008_bib83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuro.2016.12.010","article-title":"Monoamine oxidase inhibitory activity in tobacco particulate matter: are harman and norharman the only physiologically relevant inhibitors","volume":"59","author":"Truman","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2022.09.008_bib84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuro.2019.09.010","article-title":"Monoamine oxidase inhibitory activity of flavoured e-cigarette liquids","volume":"75","author":"Truman","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2022.09.008_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/151596","article-title":"Comparative effects of alpha-, beta-, and gamma-Carbolines on platelet aggregation and lipid membranes","volume":"2011","author":"Tsuchiya","year":"2011","journal-title":"J. Toxicol."},{"key":"10.1016\/j.neuro.2022.09.008_bib86","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.toxrep.2019.11.008","article-title":"Comparison of monoamine oxidase inhibition by cigarettes and modified risk tobacco products","volume":"6","author":"van der Toorn","year":"2019","journal-title":"Toxicol. Rep."},{"issue":"4","key":"10.1016\/j.neuro.2022.09.008_bib87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-009-1760-8","article-title":"Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats","volume":"208","author":"Villegier","year":"2010","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.neuro.2022.09.008_bib88","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.neuropharm.2007.02.001","article-title":"Tranylcypromine enhancement of nicotine self-administration","volume":"52","author":"Villegier","year":"2007","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.neuro.2022.09.008_bib89","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2174\/156802612805219996","article-title":"Herbal natural products as a source of monoamine oxidase inhibitors: a review","volume":"12","author":"Vina","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.neuro.2022.09.008_bib90","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10973-013-3142-z","article-title":"The important role of quinic acid in the formation of phenolic compounds from pyrolysis of chlorogenic acid","volume":"114","author":"Wang","year":"2013","journal-title":"J. Therm. Anal. Calorim."},{"issue":"8","key":"10.1016\/j.neuro.2022.09.008_bib91","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/08870446.2017.1325890","article-title":"Tobacco smoking: health impact, prevalence, correlates and interventions","volume":"32","author":"West","year":"2017","journal-title":"Psychol. Health"},{"key":"10.1016\/j.neuro.2022.09.008_bib92","series-title":"Cigarette Smoke and Oxidative Stress","first-page":"5","article-title":"Tobacco smoke constituents affecting oxidative stress","author":"Wooten","year":"2006"},{"key":"10.1016\/j.neuro.2022.09.008_bib93","unstructured":"World Health Organization. (2021). Tobacco: Key facts. Available from \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco\u3009 (accessed 4 May 2022)."},{"key":"10.1016\/j.neuro.2022.09.008_bib94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0021-9673(01)99233-7","article-title":"Free phenolic acids in cigarette smoke and tobacco paper chromatography: separation and identification","volume":"8","author":"Yang","year":"1962","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.neuro.2022.09.008_bib95","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fnmol.2019.00143","article-title":"Monoamine oxidases (MAOs) as privileged molecular targets in neuroscience: Research literature analysis","volume":"12","author":"Yeung","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.neuro.2022.09.008_bib96","first-page":"S287","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.neuro.2022.09.008_bib97","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuro.2022.09.008_bib98","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharm."},{"issue":"6","key":"10.1016\/j.neuro.2022.09.008_bib99","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0024-3205(87)90446-2","article-title":"Irreversible inhibition of monoamine-oxidase by some components of cigarette-smoke","volume":"41","author":"Yu","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.neuro.2022.09.008_bib100","first-page":"8361858","article-title":"Selectivity of dietary phenolics for inhibition of human monoamine oxidases A and B","volume":"2019","author":"Zhang","year":"2019","journal-title":"Biomed. Res Int"},{"issue":"14","key":"10.1016\/j.neuro.2022.09.008_bib101","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1039\/c3ay26499h","volume":"5","author":"Zhou","year":"2013","journal-title":"Anal. Methods"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X2200153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X2200153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:27:07Z","timestamp":1758983227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X2200153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":101,"alternative-id":["S0161813X2200153X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2022.09.008","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2022.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}